Terms: = Leukemia AND RSPO3, Q9BXY4, THSD2, PWTSR, FLJ14440, CRISTIN1, ENSG00000146374, 84870 AND Treatment
3 results:
1. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract] [Full Text] [Related]
2. Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib.
Martino B; Mammì C; Labate C; Rodi S; Ielo D; Priolo M; Postorino M; Tripepi G; Ronco F; Laganà C; Musolino C; Greco M; La Nasa G; Caocci G
Exp Hematol; 2017 Nov; 55():71-75. PubMed ID: 28757432
[TBL] [Abstract] [Full Text] [Related]
3. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
Katoh M; Katoh M
Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
[TBL] [Abstract] [Full Text] [Related]